X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (159412) 159412
Newsletter (13884) 13884
Newspaper Article (9238) 9238
Magazine Article (300) 300
Book / eBook (170) 170
Book Chapter (104) 104
Conference Proceeding (80) 80
Web Resource (55) 55
Dissertation (36) 36
Publication (21) 21
Government Document (19) 19
Reference (8) 8
Book Review (6) 6
Streaming Video (5) 5
Transcript (4) 4
Journal / eJournal (3) 3
Paper (3) 3
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (136217) 136217
female (71640) 71640
male (68165) 68165
oncology (67587) 67587
middle aged (55341) 55341
cancer (52391) 52391
lung cancer (50171) 50171
aged (48897) 48897
lung neoplasms - drug therapy (38871) 38871
adult (36893) 36893
lung neoplasms - pathology (36446) 36446
research (31263) 31263
chemotherapy (28329) 28329
animals (26160) 26160
care and treatment (24890) 24890
lung cancer, non-small cell (23540) 23540
prognosis (22041) 22041
metastasis (19794) 19794
tumors (19601) 19601
carcinoma, non-small-cell lung - drug therapy (18808) 18808
aged, 80 and over (17797) 17797
mice (17336) 17336
treatment outcome (17314) 17314
cell line, tumor (17164) 17164
lung-cancer (16236) 16236
lung neoplasms - therapy (15879) 15879
carcinoma, non-small-cell lung - pathology (15811) 15811
oncology, experimental (15669) 15669
neoplasm staging (15498) 15498
antineoplastic combined chemotherapy protocols - therapeutic use (15280) 15280
lung neoplasms - genetics (14979) 14979
radiotherapy (14376) 14376
respiratory system (14078) 14078
lung neoplasms - mortality (13839) 13839
analysis (13749) 13749
cell lung-cancer (13626) 13626
lung neoplasms - secondary (13611) 13611
surgery (13518) 13518
antineoplastic agents - therapeutic use (13475) 13475
survival (12976) 12976
cancer therapies (12938) 12938
retrospective studies (12782) 12782
apoptosis (12680) 12680
expression (12386) 12386
health aspects (12179) 12179
lung neoplasms - surgery (11876) 11876
lung neoplasms - radiotherapy (11822) 11822
lung neoplasms - metabolism (11794) 11794
carcinoma (11475) 11475
mutation (10875) 10875
genetic aspects (10330) 10330
patients (10163) 10163
therapy (10064) 10064
radiology, nuclear medicine & medical imaging (9910) 9910
combined modality therapy (9847) 9847
survival rate (9483) 9483
lung cancer, small cell (9283) 9283
lung neoplasms - diagnosis (9121) 9121
risk factors (8712) 8712
diagnosis (8598) 8598
survival analysis (8460) 8460
breast-cancer (8457) 8457
gene expression (8138) 8138
medicine & public health (8018) 8018
proteins (7954) 7954
carcinoma, non-small-cell lung - genetics (7926) 7926
follow-up studies (7919) 7919
antineoplastic agents - pharmacology (7835) 7835
hematology, oncology and palliative medicine (7717) 7717
breast cancer (7572) 7572
lung neoplasms - diagnostic imaging (7502) 7502
medicine (7470) 7470
non-small cell lung cancer (7398) 7398
carcinoma, non-small-cell lung - mortality (7392) 7392
time factors (7288) 7288
medical prognosis (7266) 7266
pharmacology & pharmacy (7246) 7246
medical research (7106) 7106
immunotherapy (7043) 7043
development and progression (7029) 7029
adenocarcinoma (6982) 6982
tomography, x-ray computed (6967) 6967
neoplasm metastasis (6965) 6965
drug therapy (6932) 6932
immunohistochemistry (6900) 6900
cell biology (6795) 6795
lungs (6775) 6775
cisplatin (6713) 6713
neoplasms - drug therapy (6533) 6533
kinases (6409) 6409
lung (6368) 6368
research article (6345) 6345
radiation therapy (6313) 6313
studies (6289) 6289
lung neoplasms (6242) 6242
gene expression regulation, neoplastic (6172) 6172
disease-free survival (6059) 6059
pathology (6055) 6055
metastases (6030) 6030
clinical trials (5982) 5982
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (58) 58
Online Resources - Online (50) 50
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (28) 28
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
St. Michael's Hospital - Stacks (5) 5
Scarborough Hospital - Online (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Reference (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Providence Healthcare - Reference (2) 2
University College (Laidlaw) - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
West Park Healthcare Centre - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Government Pubs (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
Toronto East General Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (172880) 172880
Japanese (4386) 4386
Chinese (2376) 2376
French (2355) 2355
German (2095) 2095
Russian (1207) 1207
Italian (549) 549
Spanish (521) 521
Polish (442) 442
Portuguese (179) 179
Hungarian (145) 145
Czech (124) 124
Dutch (106) 106
Danish (93) 93
Romanian (66) 66
Turkish (62) 62
Croatian (59) 59
Korean (50) 50
Serbian (46) 46
Norwegian (37) 37
Swedish (36) 36
Finnish (31) 31
Hebrew (24) 24
Ukrainian (22) 22
Bulgarian (18) 18
Lithuanian (14) 14
Icelandic (7) 7
Slovak (7) 7
Bosnian (3) 3
Arabic (2) 2
Greek (2) 2
Afrikaans (1) 1
Georgian (1) 1
Latvian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
...) durvalumab in combination with radiotherapy (RT) in an expansion cohort of patients included in a phase 1/2 trial at our institution... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
Seminars in oncology, ISSN 0093-7754, 2015, Volume 42, Issue 6, pp. 801 - 819
The fibroblast growth factor receptor (FGFR) pathway plays a major role in several biological processes, from organogenesis to metabolism homeostasis and... 
BREAST-CANCER | LUNG-CANCER | IN-VITRO | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RESISTANCE | GENE AMPLIFICATION | POTENTIAL THERAPEUTIC TARGET | PROGNOSTIC-SIGNIFICANCE | ANTITUMOR-ACTIVITY | EXPRESSION | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Brain Neoplasms - pathology | Fibroblast Growth Factors - genetics | Brain Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Gastrointestinal Neoplasms - pathology | Glioblastoma - genetics | Receptors, Fibroblast Growth Factor - genetics | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Gastrointestinal Neoplasms - metabolism | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - drug therapy | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Thoracic Neoplasms - pathology | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Thoracic Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Breast Neoplasms - genetics | Thoracic Neoplasms - genetics | Breast Neoplasms - pathology | Glioblastoma - pathology | Receptors, Fibroblast Growth Factor - metabolism | Head and Neck Neoplasms - genetics | Fibroblast Growth Factors - antagonists & inhibitors | Thoracic Neoplasms - drug therapy | Glioblastoma - drug therapy | Neoplasms - pathology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
Journal of thoracic oncology, ISSN 1556-0864, 03/2013, Volume 8, Issue 3, pp. 346 - 351
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2016, Volume 66, Issue 5, pp. 408 - 436
Answer questions and earn CME/CNE In this report, a team of surgical pathologists has provided a review of intraepithelial neoplasia in a host of (but not all)... 
carcinoma in situ | dysplasia | intraepithelial neoplasia | preinvasive neoplasia | precancer | HIGH-GRADE DYSPLASIA | URINARY-BLADDER | BARRETTS-ESOPHAGUS | HUMAN-PAPILLOMAVIRUS | INTRADUCTAL CARCINOMA | CARCINOMA IN-SITU | PAPILLARY UROTHELIAL HYPERPLASIA | ONCOLOGY | SINGLE ACADEMIC CENTER | TERM-FOLLOW-UP | NECK-CANCER IMPLICATIONS | Humans | Lung Neoplasms - metabolism | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Esophageal Neoplasms - pathology | Breast Neoplasms - therapy | American Cancer Society | Uterine Cervical Neoplasms - metabolism | Skin Neoplasms - diagnosis | Urinary Bladder Neoplasms - pathology | Female | Ovarian Neoplasms - metabolism | Uterine Cervical Neoplasms - therapy | Skin Neoplasms - pathology | Prostatic Neoplasms - pathology | Uterine Cervical Neoplasms - diagnosis | Skin Neoplasms - therapy | Carcinoma in Situ - pathology | Ovarian Neoplasms - diagnosis | Pancreatic Neoplasms - pathology | Risk Factors | Head and Neck Neoplasms - therapy | Lung Neoplasms - therapy | Carcinoma in Situ - therapy | Head and Neck Neoplasms - pathology | Skin Neoplasms - metabolism | Breast Neoplasms - pathology | Ovarian Neoplasms - therapy | Head and Neck Neoplasms - diagnosis | Breast Neoplasms - diagnosis | Carcinoma in Situ - diagnosis | Carcinoma in Situ - metabolism | Lung Neoplasms - diagnosis | Population Surveillance | Prevention | Care and treatment | Gastrointestinal system | Practice | Pathologists | Metastasis | Patients | Health aspects | Cervical cancer | Risk factors | Pathology | Usage | Diagnosis | Tumors | Medical diagnosis | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 1, pp. 127 - 135
... (O/E = 0.78; CI, 0.72–0.84), and esophagus (O/E = 0.58; CI, 0.37–0.86) SPMs. Patients receiving external-beam radiotherapy for endometrial... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiation-induced malignancies | HNPCC | Endometrial cancer | Second primary malignancies | SURGERY | LYNCH-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | 2ND PRIMARY CANCERS | RISK | CERVICAL-CANCER | RADIATION-THERAPY | UTERINE | ONCOLOGY | OVARIAN | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | United States - epidemiology | Colonic Neoplasms - genetics | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - epidemiology | Pharyngeal Neoplasms - etiology | Esophageal Neoplasms - epidemiology | Incidence | Vaginal Neoplasms - genetics | Young Adult | Neoplasms, Radiation-Induced - genetics | Endometrial Neoplasms - genetics | Lung Neoplasms - etiology | Aged, 80 and over | Intestine, Small - radiation effects | Bone Neoplasms - genetics | Neoplasms, Second Primary - genetics | Mouth Neoplasms - genetics | SEER Program | Risk Assessment | Vaginal Neoplasms - etiology | Mouth Neoplasms - etiology | Neoplasms, Second Primary - epidemiology | Mouth Neoplasms - epidemiology | Pharyngeal Neoplasms - genetics | Vaginal Neoplasms - epidemiology | Adolescent | Pharyngeal Neoplasms - epidemiology | Endometrial Neoplasms - radiotherapy | Esophageal Neoplasms - etiology | Age Factors | Neoplasms, Radiation-Induced - etiology | Urinary Bladder Neoplasms - genetics | Adult | Female | Intestinal Neoplasms - genetics | Urinary Bladder Neoplasms - epidemiology | Colonic Neoplasms - etiology | Lung Neoplasms - genetics | Urinary Bladder Neoplasms - etiology | Colonic Neoplasms - epidemiology | Intestinal Neoplasms - etiology | Intestinal Neoplasms - epidemiology | Bone Neoplasms - etiology | Neoplasms, Second Primary - etiology | Lung Neoplasms - epidemiology | Esophageal Neoplasms - genetics | Aged | Neoplasms, Radiation-Induced - epidemiology | Genetic aspects | Research | Oncology, Experimental | Cancer | Index Medicus | LARGE INTESTINE | GASTROINTESTINAL TRACT | ORAL CAVITY | ESOPHAGUS | DIGESTIVE SYSTEM | LUNGS | MEDICINE | PHARYNX | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | BLADDER | RADIOTHERAPY | RADIOLOGY | SMALL INTESTINE | NEOPLASMS | UTERUS | INTESTINES | NUCLEAR MEDICINE | FEMALE GENITALS | ORGANS | URINARY TRACT | DISEASES | RESPIRATORY SYSTEM | BRACHYTHERAPY | BODY
Journal Article
Oral oncology, ISSN 1368-8375, 2013, Volume 49, Issue 1, pp. 79 - 85
Summary Objectives To describe the natural course of distant metastases (DMs) following radiotherapy (RT... 
Otolaryngology | Hematology, Oncology and Palliative Medicine | Distant metastasis | Human papillomavirus | Oropharyngeal carcinoma | Radiotherapy | Chemoradiotherapy | SURVIVAL | HEAD | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | PHASE-III TRIAL | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | SQUAMOUS-CELL CARCINOMA | EPSTEIN-BARR-VIRUS | NECK-CARCINOMA | Oropharyngeal Neoplasms - therapy | Papillomavirus Infections - radiotherapy | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Carcinoma - virology | Salvage Therapy | Male | Papillomavirus Infections - therapy | Neoplasm Recurrence, Local - pathology | Lung Neoplasms - secondary | Tongue Neoplasms - virology | Aged, 80 and over | Adult | Female | Retrospective Studies | Tonsillar Neoplasms - therapy | Liver Neoplasms - secondary | Carcinoma - secondary | Tongue Neoplasms - radiotherapy | Liver Neoplasms - virology | Radiotherapy Dosage | Tongue Neoplasms - therapy | Alphapapillomavirus - classification | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Oropharyngeal Neoplasms - virology | Carcinoma - radiotherapy | Lung Neoplasms - virology | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - virology | Skin Neoplasms - virology | Skin Neoplasms - secondary | Carcinoma - therapy | Aged | Neoplasm Staging | Cohort Studies | Care and treatment | Metastasis | Nuclear radiation | Papillomavirus infections | Cancer
Journal Article
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 126 - 134
Purpose To perform a comprehensive cognitive function (CF) assessment in patients who were relapse free after curative intent radiotherapy (RT... 
Radiology | Hematology, Oncology and Palliative Medicine | Squamous cell carcinoma of the head and neck | Chemotherapy | Neuropsychological testing | Radiotherapy | Cognitive dysfunction | PROPHYLACTIC CRANIAL IRRADIATION | ADJUVANT CHEMOTHERAPY | DRIVING PERFORMANCE | FOLLOW-UP | CELL LUNG-CANCER | BREAST-CANCER | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | NEUROCOGNITIVE FUNCTION | LOW-GRADE GLIOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - radiotherapy | Cerebellum - radiation effects | Prospective Studies | Humans | Middle Aged | Male | Pharyngeal Neoplasms - drug therapy | Antineoplastic Agents - administration & dosage | Cognition - physiology | Laryngeal Neoplasms - drug therapy | Neoplasms, Squamous Cell - pathology | Carcinoma - drug therapy | Carcinoma - blood | Affect - physiology | Head and Neck Neoplasms - drug therapy | Cognition - drug effects | Neoplasms, Squamous Cell - blood | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell | Neuropsychological Tests | Cognition Disorders - diagnosis | Memory Disorders - etiology | Hypopharyngeal Neoplasms - pathology | Quality of Life | Pharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - drug therapy | Temporal Lobe - drug effects | Laryngeal Neoplasms - blood | Cerebellum - drug effects | Hypopharyngeal Neoplasms - blood | Cisplatin - administration & dosage | Feasibility Studies | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - blood | Antineoplastic Agents - adverse effects | Cognition Disorders - etiology | Neoplasms, Squamous Cell - drug therapy | Neoplasms, Squamous Cell - radiotherapy | Female | Carcinoma - pathology | Cognition - radiation effects | Affect - drug effects | Pharyngeal Neoplasms - blood | Affect - radiation effects | Carcinoma - radiotherapy | Combined Modality Therapy - adverse effects | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Cisplatin - adverse effects | Aged | Combined Modality Therapy - methods | Temporal Lobe - radiation effects | Care and treatment | Squamous cell carcinoma | Cancer | BODY FLUIDS | HEAD | NERVOUS SYSTEM | RADIATION DOSES | MEDICINE | THERAPY | CEREBELLUM | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | BRAIN | RADIOLOGY | BLOOD | NEOPLASMS | BIOLOGICAL MATERIALS | CENTRAL NERVOUS SYSTEM | STANDARD OF LIVING | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | CARCINOMAS | NECK | DOSIMETRY | BODY | MATERIALS
Journal Article
European urology, ISSN 0302-2838, 2014, Volume 65, Issue 2, pp. 270 - 273
Journal Article
Gut, ISSN 0017-5749, 01/2012, Volume 61, Issue 1, pp. 6 - 32
These guidelines update previous guidance published in 2005. They have been revised by a group who are members of the UK and Ireland Neuroendocrine Tumour... 
SOMATOSTATIN-RECEPTOR SCINTIGRAPHY | PANCREATIC ENDOCRINE TUMORS